These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38282144)

  • 1. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
    Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
    J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
    Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
    Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
    J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells.
    Yao H; Li J; Zhou D; Pan X; Chu Y; Yin J
    Int J Clin Oncol; 2024 Mar; 29(3):333-344. PubMed ID: 38172354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
    Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
    Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
    Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
    Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
    Li H; Tang X; Sun Z; Qu Z; Zou X
    Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
    Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
    BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1.
    Xiong Y; Shi L; Li L; Yang W; Zhang H; Zhao X; Shen N
    J Transl Med; 2024 Jul; 22(1):639. PubMed ID: 38978058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broussoflavonol B from
    Jeong JH; Ryu JH
    Molecules; 2020 May; 25(10):. PubMed ID: 32429421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forkhead box M1 mediates metabolic reprogramming in human colorectal cancer cells.
    Li PC; Dai SY; Lin YS; Chang YT; Liu CC; Wang IC; Lee MF
    Am J Physiol Gastrointest Liver Physiol; 2024 Aug; 327(2):G284-G294. PubMed ID: 38953837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy.
    Wolter P; Hanselmann S; Pattschull G; Schruf E; Gaubatz S
    Oncotarget; 2017 Feb; 8(7):11160-11172. PubMed ID: 28061449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of FOXM1 suppresses cell growth and metastasis in human laryngeal cancer via the AKT signaling pathway.
    Yan J; Hou J; Yan Y; Ren XY; Luo HN; Wang ZG; Zheng GX
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6786-6793. PubMed ID: 32633370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxM1 Regulates Proliferation and Apoptosis of Human Neuroblastoma Cell through PI3K/AKT Pathway.
    Liao J; Jiang L; Wang C; Zhao D; He W; Zhou K; Liang Y
    Fetal Pediatr Pathol; 2022 Jun; 41(3):355-370. PubMed ID: 32901528
    [No Abstract]   [Full Text] [Related]  

  • 18. Apoptotic effect of lambertianic acid through AMPK/FOXM1 signaling in MDA-MB231 breast cancer cells.
    Lee JH; Lee HJ; Sim DY; Jung JH; Kim KR; Kim SH
    Phytother Res; 2018 Sep; 32(9):1755-1763. PubMed ID: 29722086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
    Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
    Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1.
    Cınar V; Hamurcu Z; Guler A; Nurdinov N; Ozpolat B
    Breast Cancer; 2022 Nov; 29(6):1106-1120. PubMed ID: 36006564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.